Nexus Surgical and Medicare Limited held a board meeting on Thursday, 13th August, 2026 at 4:00 PM at their registered office in Palghar. The meeting concluded at 5:40 PM.
The Board of Directors approved the unaudited quarterly financial results for the quarter ended 30th June, 2026. The results were accompanied by a Limited Review Report from the statutory auditors.
Financial Performance (Quarter Ended June 30, 2026)
Income Statement (₹ in lakhs):
- Sales and Services: ₹254.80 (vs. ₹172.52 in Q1 FY26, +48% YoY)
- Other Income: ₹2.79 (vs. ₹0 in Q1 FY26)
- Total Income: ₹257.59 (vs. ₹172.52 in Q1 FY26, +49% YoY)
Expenses:
- Purchase of stock-in-trade: ₹60.29 (vs. ₹75.47 in Q1 FY26)
- Change in inventories: (₹5.28) credit (vs. (₹17.18) in Q1 FY26)
- Employee benefits expense: ₹9.21 (vs. ₹11.32 in Q1 FY26)
- Depreciation and amortization: ₹0.12 (vs. ₹0.10 in Q1 FY26)
- Other expense: ₹165.97 (vs. ₹82.43 in Q1 FY26, +101% YoY)
- Total Expenses: ₹230.31 (vs. ₹152.15 in Q1 FY26, +51% YoY)
Profitability:
- Profit before tax: ₹27.28 (vs. ₹20.38 in Q1 FY26, +34% YoY)
- Current Tax: ₹6.87 (vs. ₹5.13 in Q1 FY26)
- Tax expenses: ₹6.87 (vs. ₹5.13 in Q1 FY26)
- Net profit for the period: ₹20.42 (vs. ₹15.25 in Q1 FY26, +34% YoY)
Comparative Performance:
- Previous quarter (Q4 FY26): Net profit of ₹23.99
- Full year FY26: Net profit of ₹73.61
Capital Structure:
- Paid-up Equity Share Capital (Face Value ₹10): ₹547.19 lakhs (unchanged from previous periods)
- Basic and Diluted EPS: ₹0.37 (vs. ₹0.28 in Q1 FY26, ₹0.44 in Q4 FY26)
Additional Information
- The financial results were prepared in accordance with Indian Accounting Standards (Ind AS)
- The results were reviewed and recommended by the Audit Committee
- Statutory Auditors reviewed the results
- The company is primarily engaged in trading business with no separate reportable segments as per Ind AS 108
- No shareholder/investor complaints were received during the quarter
- Previous period figures have been regrouped/reclassified for comparability